Income Taxes	3 Months Ended
Apr. 04, 2020
Income Tax Disclosure [Abstract]
Income Taxes	NOTE 12. INCOME TAXES Our income tax expense was $4.1 million for the three months ended April 4, 2020, compared with $2.3 million for the three months ended March 30, 2019. Our effective tax rate for the three months ended April 4, 2020, was 21.0%, and was 21.7% for the three months ended March 30, 2019. Income tax expense in the three months ended April 4, 2020, and March 30, 2019, includes excess tax benefits relating to exercises of stock options and lapses of restrictions on stock awards, treated as a discrete item of income tax, totaling $767 thousand and $422 thousand, respectively. Excluding this discrete item, the effective tax rates for the three months ended April 4, 2020, and March 30, 2019, would have been 24.8% and 25.7%, respectively. Our estimated annual effective tax rate, excluding the discrete items discussed above, approximates our current combined statutory federal and state rate of 25.0%. In response to the COVID-19 outbreak, in March 2020, the U.S. Congress passed the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) legislation aimed at providing relief for individuals and businesses that have been negatively impacted by the pandemic. While we are still assessing the impact of the CARES Act legislation on the Company’s income taxes, at this time we do not expect that the CARES Act will have a material impact to our consolidated financial statements. However, during the three months ended April 4, 2020, we made no payments of estimated federal and state income taxes as the deadlines for such payments to the United States government, and the majority of states in which we have nexus, which have followed the payment deadline extension of this new Federal legislation, have been deferred until July 2020 as a result of the CARES Act.

Income Taxes

3 Months Ended

Apr. 04, 2020

NOTE 12. INCOME TAXES

Our income tax expense was $4.1 million for the three months ended April 4, 2020, compared with $2.3 million for the three months ended March 30, 2019. Our effective tax rate for the three months ended April 4, 2020, was 21.0%, and was 21.7% for the three months ended March 30, 2019.

Income tax expense in the three months ended April 4, 2020, and March 30, 2019, includes excess tax benefits relating to exercises of stock options and lapses of restrictions on stock awards, treated as a discrete item of income tax, totaling $767 thousand and $422 thousand, respectively. Excluding this discrete item, the effective tax rates for the three months ended April 4, 2020, and March 30, 2019, would have been 24.8% and 25.7%, respectively.

Our estimated annual effective tax rate, excluding the discrete items discussed above, approximates our current combined statutory federal and state rate of 25.0%.

In response to the COVID-19 outbreak, in March 2020, the U.S. Congress passed the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) legislation aimed at providing relief for individuals and businesses that have been negatively impacted by the pandemic. While we are still assessing the impact of the CARES Act legislation on the Company’s income taxes, at this time we do not expect that the CARES Act will have a material impact to our consolidated financial statements. However, during the three months ended April 4, 2020, we made no payments of estimated federal and state income taxes as the deadlines for such payments to the United States government, and the majority of states in which we have nexus, which have followed the payment deadline extension of this new Federal legislation, have been deferred until July 2020 as a result of the CARES Act.